GlobeImmune
GlobeImmune is engaged in the development of therapeutic Tarmogen vaccines for the treatment of cancer and infectious diseases.
Business Model:
Revenue: $6.2M
Employees: 11-50
Rankings
Industries / Tags:
Detailed GlobeImmune Information
Geographic Data
Address: 1450 Infinite Drive
City: Louisville
State: CO
Zip: 80027
Country: US
Financial Info
Stage:
series unknown
Raised Last:
$392k
Raised Total:$96M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
GlobeImmune is engaged in the development of therapeutic Tarmogen vaccines for the treatment of cancer and infectious diseases.
Contact Phone:
+13036252700
Contact Email:
GlobeImmune went public on 7/5/2016 on the OTCMKTS
Listed Exchange:
OTCMKTS
IPO Date:
7/5/2016
Ticker Symbol:
GBIM
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
